Dirk Hose
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Peptidase Inhibition and Analysis
Papers in
- Hematology 151
- Multiple Myeloma Research and Treatments 148
-
- Protein Degradation and Inhibitors 39
- Amyloidosis: Diagnosis, Treatment, Outcomes 20
- Glycosylation and Glycoproteins Research 20
- Ubiquitin and proteasome pathways 17
- Co-authors
- Hartmut Goldschmidt (136 shared papers)Bernard Klein (85 shared papers)Jérôme Moreaux (70 shared papers)Thierry Rème (52 shared papers)Anja Seckinger (94 shared papers)John De Vos (30 shared papers)Anna Sophia Jauch (53 shared papers)Alboukadel Kassambara (20 shared papers)
- Journals
- Blood (59 papers)Haematologica (14 papers)Leukemia (10 papers)Oncotarget (9 papers)British Journal of Haematology (6 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Dirk Hose
208 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 123
- Hematology 3.5k
- Oncology 2.0k
- Genetics 687
- Molecular Biology 4.2k
- Immunology 1.1k
Countries citing papers authored by Dirk Hose
This map shows the geographic impact of Dirk Hose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hose more than expected).
Fields of papers citing papers by Dirk Hose
This network shows the impact of papers produced by Dirk Hose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hose. The network helps show where Dirk Hose may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Hose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 235 | |
| 2 | 2009 | 221 | |
| 3 | 2005 | 209 | |
| 4 | 2009 | 203 | |
| 5 | 2006 | 200 | |
| 6 | 2015 | 169 | |
| 7 | 2013 | 168 | |
| 8 | 2010 | 159 | |
| 9 | 2004 | 135 | |
| 10 | 2009 | 134 | |
| 11 | 2010 | 131 | |
| 12 | 2010 | 124 | |
| 13 | 2007 | 121 | |
| 14 | 2014 | 115 | |
| 15 | 2011 | 114 | |
| 16 | 2015 | 112 | |
| 17 | 2009 | 111 | |
| 18 | 2012 | 109 | |
| 19 | 2007 | 98 | |
| 20 | 2012 | 93 |
About Dirk Hose
Dirk Hose is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 216 papers that have together received 7.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (148 papers), Protein Degradation and Inhibitors (39 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Glycosylation and Glycoproteins Research (20 papers), Ubiquitin and proteasome pathways (17 papers), Peptidase Inhibition and Analysis (16 papers), Immunotherapy and Immune Responses (15 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). The work is most often cited by research in Hematology (3.5k citations), Oncology (2.0k citations), Genetics (687 citations), Molecular Biology (4.2k citations) and Immunology (1.1k citations). Dirk Hose has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Hartmut Goldschmidt, Bernard Klein, Jérôme Moreaux, Thierry Rème, Anja Seckinger, John De Vos, Anna Sophia Jauch, Alboukadel Kassambara, Jens Hillengaß and Anthony Dick Ho. Their work appears in journals such as Blood, Haematologica, Leukemia, Oncotarget and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.